Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G/A - Processa Pharmaceuticals, Inc. | StockGist | StockGist

Companies
PCSA
SCHEDULE 13G/A

Home Top Movers Companies Concepts

Home Filings PCSASCHEDULE 13G/A

SCHEDULE 13G/A

Beneficial Ownership

Amendment

Processa Pharmaceuticals, Inc.

Filed Feb 13, 2026

Accepted Feb 12, 2026, 7:00 PM ET

CIK 0001533743

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Shares Owned

200,000

Reporting Person

Processa Pharmaceuticals, Inc.

Person Type

HC

CUSIP: 74275C403

Amendment History

5 filings

SCHEDULE 13G
Original
Jun 24, 20250001649553-25-000111
SCHEDULE 13G/A
Amendment 1
Aug 12, 20250001213900-25-075086
SCHEDULE 13G/A
Amendment 2
Aug 14, 20250001172661-25-003607
SCHEDULE 13G/A
Amendment 3
Aug 14, 20250001649553-25-000158
SCHEDULE 13G/A
Amendment 4
Latest
Viewing
Feb 13, 20260001213900-26-016520

Key Facts

Shares Owned

200,000

Recent Filings

Processa Pharmaceuticals, Inc.1 months ago

Processa Pharmaceuticals, Inc.2 months ago

Processa Pharmaceuticals, Inc.3 months ago

Processa Pharmaceuticals, Inc.4 months ago

Processa Pharmaceuticals, Inc.4 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice